|
|
About 100 new prescription or over-the-counter drugs come into the U.S. market every year.
Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.
Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.
According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.